A Pharmacokinetic Study of NTI164 in Healthy Adult Volunteers
Latest Information Update: 09 Dec 2024
Price :
$35 *
At a glance
- Drugs NTI 164 (Primary)
- Indications Obsessive-compulsive disorders; Pervasive child development disorders; Rett syndrome
- Focus Pharmacokinetics
- 09 Dec 2024 New trial record